522 results on '"Kefford, R"'
Search Results
152. Heterogeneity of X-ray damage induction and repair in human malignant melanoma (MM) cell lines
153. Prognostic value of quality of life (QL) scores in a clinical trial of dacarbazine (DTIC) with or without interferon-alpha2a (IFN) in patients with metastatic malignant melanoma (MMM)
154. Molecular genetics of melanoma
155. Multiple levels of post-transcriptional regulation of collagenase (matrix metalloproteinase 1) in an epithelial cell line
156. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma
157. Investigation of loss of heterozygosity at specific loci on chromosomes 3p, 6q, 11p, 17p and 17q in ovarian cancer
158. Germ cell tumours of the testis
159. Post-transcriptional regulation of urokinase plasminogen activator gene expression occurs in the nucleus of BC1 rat mammary tumor cells
160. Targeting BRAF for patients with melanoma.
161. Single institutional experience with non‐seminomatous germ cell tumours of the testis: local perspectives on a curable cancer
162. Conservation and Potential Role of RNA-Instability Motifs in Urokinase Gene 3'-Untranslated Sequences
163. A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma.
164. Association between circulating white blood cell count and cancer mortality: a population-based cohort study.
165. Multiple abnormalities of the p16INK4a-pRb regulatory pathway in cultured melanoma cells.
166. Renal phosphate threshold and response to pamidronate in humoral hypercalcaemia of malignancy.
167. Amplification of HER-2/neu oncogene in human ovarian cancer.
168. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
169. Harvey-ras oncogene restriction fragment alleles in familial melanoma kindreds.
170. Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer.
171. Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.
172. Clinicopathological presentations of oral Kaposi's sarcoma in AIDS.
173. Demonstration of somatic rearrangements and genomic heterogeneity in human ovarian cancer by DNA fingerprinting.
174. Phorbol esters potentiate the induction of class I HLA expression by interferon alpha.
175. 10q Deletions in Metastatic Cutaneous Melanoma
176. Sequence and evolution of the human T-cell antigen receptor beta-chain genes.
177. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression.
178. The impact of Granulocyte-Colony Stimulating Factor (G-CSF) and Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) on cancer therapy. In Accomplishements in Cancer Research 1989 Eds, General Motor Cancer Research Foundation, Philadelphia PAN, Lippincott, 1990, pp204-211
179. Epirubicin: a phase II study in recurrent small-cell lung cancer.
180. Bone metastases in hypernephroma. Frequency of scapular involvement.
181. Amplification of c- ras-ki oncogene in human ovarian tumours.
182. Dexamethasone decreases urokinase plasminogen activator mRNA stability in MAT 13762 rat mammary carcinoma cells.
183. PLENARY.
184. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus
185. Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: An overview
186. Locally advanced and inflammatory breast cancer
187. Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia
188. Correlates of outcome in patients with metastatic melanoma treated with dacarbazine
189. Adverse events (AEs) over time in patients (pts) treated with adjuvant dabrafenib plus trametinib (D plus T) or placebo (Pbo) in the COMBI-AD trial
190. Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds
191. A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage TV metastatic melanoma
192. SCL gene in human tumors
193. Sentinel node biopsy for melanoma: The medical oncology perspective
194. Functional impairment of melanoma-associated p16INK4amutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding
195. Confirmation of chromosome 9p linkage in familial melanoma
196. Updated relapse-free survival (RFS) and biomarker analysis in the COMBI-AD trial of adjuvant dabrafenib plus trametinib (D plus T) in patients (pts) with resected BRAF V600-mutant stage III melanoma
197. A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract.
198. A Comparison of Obstetric Performance Between an Asian and Caucasian Population in East London
199. Health‐care interpreters and cancer
200. INTRACAVITARY ADRIAMYCIN NITROGEN MUSTARD AND TETRACYCLINE IN THE CONTROL OF MALIGNANT EFFUSIONS: A RANDOMIZED STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.